Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Buy
54
SHC Quote, Financials, Valuation and Earnings
Last price:
$11.28
Seasonality move
:
-8.52%
Day range:
$11.21 - $11.44
52-week range:
$9.53 - $17.08
Dividend yield:
0%
P/E ratio:
140.38x
P/S ratio:
2.89x
P/B ratio:
7.70x
Volume:
987.1K
Avg. volume:
1.3M
1-year change:
-12.95%
Market cap:
$3.2B
Revenue:
$1.1B
EPS (TTM):
$0.08
Analysts' Opinion
-
Consensus RatingSotera Health has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $14.91, Sotera Health has an estimated upside of 32.16% from its current price of $11.23.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $13.00 representing -15.76% downside risk from its current price of $11.23.
Fair Value
-
According to the consensus of 7 analysts, Sotera Health has 32.16% upside to fair value with a price target of $14.91 per share.
SHC vs. S&P 500
-
Over the past 5 trading days, Sotera Health has underperformed the S&P 500 by -3.33% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Sotera Health does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sotera Health has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Sotera Health reported revenues of $254.5M.
Earnings Growth
-
Sotera Health earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Sotera Health reported earnings per share of -$0.05.
Enterprise value:
5.1B
EV / Invested capital:
--
Price / LTM sales:
2.89x
EV / EBIT:
20.27x
EV / Revenue:
4.61x
PEG ratio (5yr expected):
--
EV / Free cash flow:
48.20x
Price / Operating cash flow:
30.21x
Enterprise value / EBITDA:
12.27x
Gross Profit (TTM):
$610.6M
Return On Assets:
0.8%
Net Income Margin (TTM):
2.24%
Return On Equity:
5.79%
Return On Invested Capital:
0.94%
Operating Margin:
22.41%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $987.5M | $1.1B | $1.1B | $248.2M | $254.5M | |
| Gross Profit | $539.6M | $592.8M | $610.6M | $127.1M | $135.4M | |
| Operating Income | $228.2M | $296.5M | $301.5M | $53.2M | $57M | |
| EBITDA | -$35.3M | $426.2M | $415.8M | $93.2M | $66.9M | |
| Diluted EPS | -$0.93 | $0.19 | $0.08 | $0.02 | -$0.05 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $328.4M | $371.6M | $923.8M | $487.2M | $555M | |
| Total Assets | $2.8B | $2.8B | $3.4B | $3.1B | $3.1B | |
| Current Liabilities | $138M | $143.9M | $600.1M | $152.3M | $226M | |
| Total Liabilities | $2.3B | $2.2B | $3.1B | $2.6B | $2.7B | |
| Total Equity | $465.7M | $642.1M | $361.1M | $429.4M | $414.1M | |
| Total Debt | $1.8B | $1.7B | $2.2B | $2.2B | $2.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $261.9M | -$171.9M | $270M | $9.7M | $55.5M | |
| Cash From Investing | -$191.4M | -$204.8M | -$164M | -$34.9M | -$19.9M | |
| Cash From Financing | $472.1M | -$19.9M | -$46.7M | -$11.9M | -$8.1M | |
| Free Cash Flow | $70M | -$376.8M | $105.9M | -$25.2M | $35.6M | |
SHC
Sector
Market Cap
$3.2B
$34.4M
Price % of 52-Week High
65.75%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.01%
1-Year Price Total Return
-12.95%
-37.36%
Beta (5-Year)
--
0.614
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$11.56
200-day SMA
Sell
Level
$13.06
Bollinger Bands (100)
Sell
Level
10.98 - 12.66
Chaikin Money Flow
Sell
Level
-764.8K
20-day SMA
Sell
Level
$11.39
Relative Strength Index (RSI14)
Sell
Level
42.27
ADX Line
Sell
Level
18.91
Williams %R
Neutral
Level
-75
50-day SMA
Sell
Level
$12.05
MACD (12, 26)
Buy
Level
3.14
25-day Aroon Oscillator
Sell
Level
-20
On Balance Volume
Sell
Level
-703.6K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.3829)
Sell
CA Score
(Annual)
Level (-1.5887)
Buy
Beneish M-Score
(Annual)
Level (-2.8068)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (2.1557)
Buy
Piotroski F Score
(Annual)
Level (7)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.
Stock Forecast FAQ
In the current month, SHC has received 4 Buy ratings 3 Hold ratings, and 0 Sell ratings. The SHC average analyst price target in the past 3 months is $14.91.
-
Where Will Sotera Health Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sotera Health share price will rise to $14.91 per share over the next 12 months.
-
What Do Analysts Say About Sotera Health?
Analysts are divided on their view about Sotera Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sotera Health is a Sell and believe this share price will drop from its current level to $13.00.
-
What Is Sotera Health's Price Target?
The price target for Sotera Health over the next 1-year time period is forecast to be $14.91 according to 7 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is SHC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sotera Health is a Buy. 4 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SHC?
You can purchase shares of Sotera Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sotera Health shares.
-
What Is The Sotera Health Share Price Today?
Sotera Health was last trading at $11.28 per share. This represents the most recent stock quote for Sotera Health. Yesterday, Sotera Health closed at $11.23 per share.
-
How To Buy Sotera Health Stock Online?
In order to purchase Sotera Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
How High Can SharkNinja Stock Go?
If you know popular consumer appliance brands Shark and Ninja,…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 6.88% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 0.79% over the past day.
Sell
42
VLCN alert for Jul 17
Volcon [VLCN] is up 210.05% over the past day.
